Department of Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
Gastroenterology. 2023 Oct;165(4):891-908.e14. doi: 10.1053/j.gastro.2023.05.036. Epub 2023 May 30.
BACKGROUND & AIMS: As pancreatic ductal adenocarcinoma (PDAC) continues to be recalcitrant to therapeutic interventions, including poor response to immunotherapy, albeit effective in other solid malignancies, a more nuanced understanding of the immune microenvironment in PDAC is urgently needed. We aimed to unveil a detailed view of the immune micromilieu in PDAC using a spatially resolved multimodal single-cell approach.
We applied single-cell RNA sequencing, spatial transcriptomics, multiplex immunohistochemistry, and mass cytometry to profile the immune compartment in treatment-naïve PDAC tumors and matched adjacent normal pancreatic tissue, as well as in the systemic circulation. We determined prognostic associations of immune signatures and performed a meta-analysis of the immune microenvironment in PDAC and lung adenocarcinoma on single-cell level.
We provided a spatially resolved fine map of the immune landscape in PDAC. We substantiated the exhausted phenotype of CD8 T cells and immunosuppressive features of myeloid cells, and highlighted immune subsets with potentially underappreciated roles in PDAC that diverged from immune populations within adjacent normal areas, particularly CD4 T cell subsets and natural killer T cells that are terminally exhausted and acquire a regulatory phenotype. Differential analysis of immune phenotypes in PDAC and lung adenocarcinoma revealed the presence of extraordinarily immunosuppressive subtypes in PDAC, along with a distinctive immune checkpoint composition.
Our study sheds light on the multilayered immune dysfunction in PDAC and presents a holistic view of the immune landscape in PDAC and lung adenocarcinoma, providing a comprehensive resource for functional studies and the exploration of therapeutically actionable targets in PDAC.
由于胰腺导管腺癌(PDAC)持续对治疗干预措施具有抗性,包括对免疫疗法的反应不佳,尽管免疫疗法在其他实体恶性肿瘤中有效,但迫切需要更细致地了解 PDAC 中的免疫微环境。我们旨在使用空间分辨多模式单细胞方法揭示 PDAC 中免疫微环境的详细视图。
我们应用单细胞 RNA 测序、空间转录组学、多重免疫组化和质谱细胞术来分析未经治疗的 PDAC 肿瘤及其匹配的相邻正常胰腺组织以及全身循环中的免疫区室。我们确定了免疫特征的预后相关性,并对 PDAC 和肺腺癌的免疫微环境进行了单细胞水平的荟萃分析。
我们提供了 PDAC 免疫景观的空间分辨精细图谱。我们证实了 CD8 T 细胞的耗竭表型和髓样细胞的免疫抑制特征,并强调了具有潜在未被充分认识的作用的免疫亚群,这些亚群与相邻正常区域内的免疫群体不同,特别是 CD4 T 细胞亚群和自然杀伤 T 细胞,它们处于终末耗竭状态并获得调节表型。PDAC 和肺腺癌中免疫表型的差异分析揭示了 PDAC 中存在异常免疫抑制亚型,以及独特的免疫检查点组成。
我们的研究揭示了 PDAC 中多层次的免疫功能障碍,并提供了 PDAC 和肺腺癌免疫景观的整体视图,为功能研究和探索 PDAC 中具有治疗作用的靶点提供了全面的资源。